Europe NSCLS Drugs Market Size, Share and Growth By Type, By Application and By Country (U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux, Rest of Europe) Forecast 2025-2033

Report ID : MS93563
Author : Market Strides
Last Updated : Jan 06, 2025
Pages : 145
Starting From
USD 1850
Buy Now

Table Of Content

  1. Executive Summary
    1. Introduction
  2. Market Introduction
    1. Market Definition
    2. Scope of the Study
    3. Market Structure
  3. Research Methodology
    1. Primary Research
    2. Research Methodology
    3. Assumptions & Exclusions
    4. Secondary Data Sources
  4. Market Factor Analysis
    1. Value Chain Analysis: Europe Nscls Drugs Market
    2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
  6. Recent Trends Analysis
  7. Impact of COVID-19 on Europe Nscls Drugs Market
    1. Pre and Post Covid -19 Market Scenario Analysis
    2. Market Recovery Timeline and Challenge
    3. Measures Taken by Top Players
  8. Regulatory Landscape
  9. Europe Nscls Drugs Market, By Type
    1. Introduction
      1. Market Size and Forecast, By Type
    2. EGFR Targeting
      1. Market Size and Forecast, By Region
    3. ALK Targeting
      1. Market Size and Forecast, By Region
    4. PD-1/PD-L1 Targeting
      1. Market Size and Forecast, By Region
    5. Gemcitabine
      1. Market Size and Forecast, By Region
    6. Cisplatin/Carboplatin
      1. Market Size and Forecast, By Region
    7. Pemetrexed
      1. Market Size and Forecast, By Region
    8. Paclitaxel
      1. Market Size and Forecast, By Region
    9. Others
      1. Market Size and Forecast, By Region
  10. Europe Nscls Drugs Market, By Application
    1. Introduction
      1. Market Size and Forecast, By Application
    2. 30 Years Old
      1. Market Size and Forecast, By Region
    3. 31 - 45 Years Old
      1. Market Size and Forecast, By Region
    4. 46 - 60 Years Old
      1. Market Size and Forecast, By Region
    5. 60 Years Old
      1. Market Size and Forecast, By Region
  11. Regional Overview
    1. Introduction
      1. Market Size and Forecast
  12. Competitive Landscape, 2024
    1. Introduction
    2. Europe Nscls Drugs Market Share Analysis, 2024 (%)
      1. Market Share Analysis, 2024
      2. Competition Ranking, 2024
      3. Key Developments & Growth Strategies
        1. Merger & Acquisition
        2. Product Launch
        3. Expansion
      4. Consolidated SWOT Analysis of Key Players
  13. Company Profile
    1. Roche
      1. Business Overview
      2. Financial Data
      3. Key Product Categories
      4. Recent Developments
    2. Novartis
    3. Pfizer
    4. Merck
    5. Bristol-Myers Squibb
    6. Eli Lilly and Company
    7. Takeda Pharmaceutical
    8. Boehringer-Ingelheim
    9. AstraZeneca
    10. Betta Pharmaceuticals
    11. Qilu Oharmaceutical
    12. Pierre Fabre Medicament
    13. Chemo Wanbang Biopharma
    14. Hetero Drugs
    15. Harbin Gloria Pharmaceuticals
    16. Luoxin Pharmaceutical
    17. Teva Pharmaceutical
    18. Mylan
    19. Sun Pharmaceutical
    20. Fosun Pharma

	

A PHP Error was encountered

Severity: Warning

Message: Undefined array key "list_tbl_fig"

Filename: reports/toc.php

Line Number: 79

Backtrace:

File: /var/www/html/application/views/frontend/reports/toc.php
Line: 79
Function: _error_handler

File: /var/www/html/application/controllers/Web.php
Line: 215
Function: view

File: /var/www/html/index.php
Line: 316
Function: require_once

Key Topics Covered
  • Market Factors (Including Drivers and Restraint)
  • Market Trends
  • Market Estimates and Forcasts
  • Competitive Analysis
  • Future Market Opportunities
Secured & Verified Premium Quality SSL Certification

Payments Methods